Evaluation of the efficacy of modern wound care dressings in the complex treatment of purulent wounds

Abstract

Objective. Evaluate the efficacy of the treatment of purulent skin and soft tissue  wounds using modern interactive dressings  and conventional wound care dressings. Material and methods.  The study included 160 patients, who were treated at the outpatient department of the Clinic of the SamGMU for the period from September  2018 to January 2019 after an autopsy,  necrosectomy  and drainage  of purulent foci in the surgical hospital. Group I (n  = 82) included patients, who applied Sorbalgon® interactive dressing (Paul Hartmann, Germany) during the first phase of the wound healing and Branolind®  N atraumatic mesh dressing (Paul Hartmann, Germany) during the second phase of the wound healing  for topical  treatment of wounds in the  postoperative period.  Patients of Group II (n   =  78)  applied  ointment dressings using Levomekol ointment during the first phase of the wound healing and Methyluracil ointment during the second phase of the wound healing. Patients in both groups received the same broad spectrum  antibacterial therapy. In Group I, the dressings  were applied once per 2 days, in Group II the dressings  were applied on a daily basis. The researchers studied  the  following indicators:  the  nature  of the  wound discharge;  the  presence  of edema  and hyperemia  of tissues; timing of the wound defect cleansing; temperature and leukocyte reactions  of the body; crops on microflora and sensitivity to antibiotic therapy. Results.  The study showed more pronounced  dynamics of the  temperature reaction normalization, reduction of the  local inflammatory reaction and the leukocytosis  level in patients of Group I. The wound cleansing  from pus and fibrin,  the development of granulation tissue on Day 5 were reported  in 87.8% of patients of Group I and in 35.9% of patients of Group II, on Day 10 in 100% and 88.5% of patients, respectively. Conclusion. The use of Sorbalgon® and Branolind® N dressings  improves the  results  of treatment of patients with purulent soft tissues pathology and reduces the risk for secondary infection, and improves the quality of life due to increase of interval between the dressings.